相关实验视频

Updated: Jul 15, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

糖化血红素A1c,大脑小血管疾病负担和帕金森病的疾病严重程度

Xinxin Ma¹, Shuhua Li¹, Fengzhi Liu¹

¹Department of Neurology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 Da HuaRoad, DongDan, Beijing, 100730, P.R. China.

Annals of clinical and translational neurology

|September 26, 2023

概括

较高的HbA1c水平与帕金森病的严重程度有关,独立于糖尿病. 大脑小血管疾病负担似乎不会在PD患者中调解这种关联.

科学领域:

神经学神经学
代谢障碍代谢障碍代谢障碍
神经成像是一种神经成像.

背景情况:

帕金森病 (PD) 是一种具有复杂病理生理学的神经退行性疾病.
葡萄糖代谢及其对PD进展的影响尚未完全理解.
大脑小血管疾病 (CSVD) 在PD中很常见,可能会影响疾病的严重程度.

研究的目的:

与对照人群相比,研究PD患者的葡萄糖水平.
为了确定血糖控制是否与PD严重程度有关,无论糖尿病状况如何.
测试CSVD负担是否调解葡萄糖控制和PD严重程度之间的关系.

主要方法:

100名PD患者和100名对照患者接受了脑部MRI.
收集了临床数据和血液参数 (FBG,HbA1c,脂质).
根据Hoehn和Yahr (H&Y) 阶段对PD患者进行了分层;评估了CSVD标志物.
多变量后勤回归分析了HbA1c和H&Y阶段之间的关联,包括与CSVD负担的相互作用.

主要成果:

与对照组相比,PD患者的HbA1c较高,脂质概况变化较大.
晚期PD患者的HbA1c比早期PD患者高.
升高的HbA1c,更长的疾病持续时间和更高的UPDRS III分数与PD严重程度的增加相关 (更高的H&Y阶段).
在PD严重程度方面,没有发现HbA1c和CSVD负担之间的显著相互作用.

结论:

糖化血红素A1c (HbA1c) 与帕金森病的严重程度 (H&Y阶段) 独立相关.
观察到的HbA1c和PD严重程度之间的关联可能不是由大脑小血管疾病负担介导的.

更多相关视频

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.